-
Finland's Eurovision favourite brings flames and a frantic violin to Vienna
-
ECB set to hold rates despite Iran war energy shock
-
Iran, World Cup loom over FIFA Congress
-
Samsung Electronics posts record quarterly profit on AI boom
-
D4vd used Amazon chainsaws to hack up teen's body: prosecutors
-
Meta chief Zuckerberg doubles down on AI spending
-
Saudi to end LIV Golf funding this year: reports
-
Google-parent Alphabet soars as Meta stumbles over AI costs
-
Powell's decision to stay on at Fed ignites new Trump insult
-
Brazil lowers benchmark rate to 14.5% in second consecutive cut
-
'This cannot happen': Arsenal's Arteta livid over Eze penalty review
-
Air quality improving in Europe but more effort needed: report
-
Putin, Trump discuss Iran, Ukraine in phone call: Kremlin
-
Crazy flights: Kiss frontman produces plane disaster movie
-
Google-parent Alphabet soars as rivals stumble over AI costs
-
Romanian behind 'swatting' attacks in US gets four years in prison
-
Arsenal, Atletico trade penalties in Champions League semi-final draw
-
Anti-Bezos campaign urges Met Gala boycott in New York
-
African oil producers defend need to drill at fossil fuel exit talks
-
Iran officials leave Canada before FIFA Congress over airport 'insult': Iranian media
-
Oil spikes while divided Federal Reserve keeps interest rates unchanged
-
Palace boss Glasner eager for another trophy in Europe
-
Alleged Trump assassin took selfie moments before attack: prosecutors
-
Shomrim: the Jewish volunteers protecting their community
-
Powell to bow out as Fed chief but stay as a governor on legal pressure
-
PSG blow as Hakimi ruled out of Champions League semi-final return
-
'Gritty' Philadelphia pitches itself as low-cost US World Cup choice
-
'I literally was a fool': Musk grilled in OpenAI trial
-
OpenAI facing 'waves' of US lawsuits over Canada mass shooting
-
Trump says US has 'a shot' at crewed Moon landing before presidency ends
-
Hungary's Magyar pushes to unblock EU billions in Brussels
-
London police probe 'terror' incident after two Jewish men stabbed
-
Rob Reiner autopsy report not ready, court hears
-
Rickelton ton in vain as Hyderabad chase down 244 to beat Mumbai
-
US Fed divided at Powell's likely last meeting at helm
-
Draper out of French Open in fresh injury blow
-
King Charles touts 'solidarity' with US at 9/11 memorial
-
Ticket price hikes not affecting summer air travel demand: IATA
-
Liverpool 'expect Salah to be available' before Anfield exit
-
World snooker champion Zhao Xintong succumbs to 'Crucible curse'
-
Australia FM says China agrees to collaborate on jet fuel exports
-
Pentagon chief spars with Democratic lawmakers on Iran war
-
Hungary's Magyar pushes to unblock EU billion in Brussels
-
Departing US still owes money, says WHO chief
-
Joshua warm-up defeat would 'kill' Fury fight, warns promoter Warren
-
Sinner stops Jodar to book spot in Madrid Open semis
-
Pogacar wins opening full stage to take Tour de Romandie lead
-
'River on fire': Toxic fumes as Ukrainian drones pound Russian oil town
-
Pereira aiming to bring European glory back to Forest
-
Uber adds hotel booking in push to become 'everything app'
Releaf Acquires Domain Releaf.com for £110,000
The UK's fastest-growing medicinal cannabis clinic begins international strategy with further online investment.
NOTTINGHAM, ENGLAND / ACCESS Newswire / September 2, 2025 / Releaf, the UK's fastest-growing medicinal cannabis clinic, has acquired the domain Releaf.com for £110,000 as part of its global expansion strategy. The move comes as the company overtakes £2.1 million in monthly revenue and prepares to take its proven healthcare model to international markets.
Releaf's technology platform, fully integrated with the NHS Spine, now serves over 300,000 unique website visitors monthly. The platform uses AI-assisted triage to match patients with specialist prescribers and delivers doctor-led care directly to patients' doors, effectively removing traditional barriers to access.
Jon Dunn, Marketing Director at Releaf, explains, "Releaf.com is our launchpad for global growth. This isn't just a domain, it's our passport to every market we enter. It gives us instant credibility, makes our brand unforgettable, and ensures patients worldwide know exactly where to find us."
The company has achieved significant growth in the UK market, onboarding over 120 new patients daily and conducting more than 300 consultations each day. This momentum is driving substantial expansion, with plans to double clinical operations month-on-month to reach over 6,000 initial consultation slots per month by year end.
Having demonstrated its approach works in the UK's highly regulated healthcare environment, Releaf is now positioning its technology-led model for international rollout. The company is targeting markets where patients face similar structural challenges in accessing cannabinoid healthcare.
Releaf continues to reinvest into clinician onboarding, patient support, and platform enhancements, ensuring high standards of care while building capacity for international expansion. With European operations already underway, the company is well-positioned to become a leading provider of regulated cannabinoid healthcare globally.
About Releaf
Launched in 2024, Releaf Dispensary Ltd the UK's fastest-growing and most-trusted* medical cannabis clinic, serving patients through its advanced healthtech platform. With a prescriber network of over 40 specialists, we deliver evidence-based cannabinoid care directly to patients' homes through tailored treatment plans.Fully integrated with NHS systems, Releaf has transformed access to medicinal cannabis treatment in the UK and is now expanding internationally. *According to Trustpilot.
Media Contact: Sophie Stephen, Marketing Manager, [email protected]
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: Releaf Dispensary Ltd
View the original press release on ACCESS Newswire
A.Williams--AT